Long‐term clinical outcomes of real‐world experience using sirolimus‐eluting stents in saphenous vein graft disease

Abstract

Our results support that SES used in SVG lesions result in a reduction in TLR without an increased risk of mortality, and therefore may be an equally safe and feasible technique for revascularization with excellent long-term clinical outcomes. These patients may benefit from prolonged dual antiplatelet and statin medication regimens.